Header Logo

Sami Ibrahimi

TitleProf,Asst
InstitutionUniversity of Oklahoma Health Sciences Center
DepartmentMedicine Hematology/Oncology
AddressSOCC 6
800 NE 10th St
Oklahoma City OK 73104
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Davis O, Lessani C, Kasht R, Cohoon A, Ibrahimi S, Asch A, Day S, Al-Juhaishi T. Impact of Primary Disease Site of Involvement by Early-Stage Follicular Lymphoma on Patient Outcomes. Clin Lymphoma Myeloma Leuk. 2024 Jul 15. PMID: 39147647.
      Citations:    Fields:    
    2. Davis O, Truong D, Day S, Pandey M, Ibrahimi S, Khawandanah M, Holter-Chakrabarty J, Asch A, Al-Juhaishi T. Impact of primary organ site of involvement by peripheral T-cell lymphoma not otherwise specified on survival. Cancer Med. 2023 Dec 11. PMID: 38073461.
      Citations: 1     Fields:    Translation:Humans
    3. MacDougall K, Day S, Hall S, Zhao D, Pandey M, Ibrahimi S, Khawandanah M, Chakrabarty JH, Asch A, Nipp R, Al-Juhaishi T. Impact of Race and Age and their Interaction on Survival Outcomes in Patients With Diffuse Large B-Cell Lymphoma. Clin Lymphoma Myeloma Leuk. 2023 05; 23(5):379-384. PMID: 36813625.
      Citations: 2     Fields:    Translation:Humans
    4. Kamdar M, Solomon SR, Arnason J, Johnston PB, Glass B, Bachanova V, Ibrahimi S, Mielke S, Mutsaers P, Hernandez-Ilizaliturri F, Izutsu K, Morschhauser F, Lunning M, Maloney DG, Crotta A, Montheard S, Previtali A, Stepan L, Ogasawara K, Mack T, Abramson JS. Lisocabtagene maraleucel versus standard of care with salvage chemotherapy followed by autologous stem cell transplantation as second-line treatment in patients with relapsed or refractory large B-cell lymphoma (TRANSFORM): results from an interim analysis of an open-label, randomised, phase 3 trial. Lancet. 2022 06 18; 399(10343):2294-2308. PMID: 35717989.
      Citations: 199     Fields:    Translation:HumansCTClinical Trials
    5. Borogovac A, Keruakous A, Bycko M, Holter Chakrabarty J, Ibrahimi S, Khawandanah M, Selby GB, Yuen C, Schmidt S, Autry MT, Al-Juhaishi T, Wieduwilt MJ, Asch AS. Safety and feasibility of outpatient chimeric antigen receptor (CAR) T-cell therapy: experience from a tertiary care center. Bone Marrow Transplant. 2022 06; 57(6):1025-1027. PMID: 35411106.
      Citations: 16     Fields:    Translation:Humans
    6. Al-Juhaishi T, Borogovac A, Ibrahimi S, Wieduwilt M, Ahmed S. Reappraising the Role of Allogeneic Hematopoietic Stem Cell Transplantation in Relapsed and Refractory Hodgkin's Lymphoma: Recent Advances and Outcomes. J Pers Med. 2022 Jan 18; 12(2). PMID: 35207613.
      Citations: 2     
    7. Afzal A, Esmaeili A, Ibrahimi S, Farooque U, Gehrs B. Monomorphic Epitheliotropic Intestinal T-Cell Lymphoma With Extraintestinal Areas of Peripheral T-Cell Lymphoma Involvement. Cureus. 2020 Aug 25; 12(8):e10021. PMID: 32983716.
      Citations: 1     
    8. Assi HA, Asch AS, Machiorlatti M, Vesely SK, Ibrahimi S. Development of thrombocytopenia is associated with improved survival in patients treated with immunotherapy. Future Sci OA. 2020 Jun 25; 6(7):FSO581. PMID: 32802390.
      Citations: 8     
    9. Ibrahimi S, Mukherjee S, Alhyari L, Rubin E, Aljumaily R. Spontaneous Regression of Metastatic Pancreatic Cancer: A Role for Recurrent Inflammation. Pancreas. 2019 01; 48(1):e4-e6. PMID: 30531247.
      Citations: 2     Fields:    Translation:Humans
    10. Wang Z, Aguilar EG, Luna JI, Dunai C, Khuat LT, Le CT, Mirsoian A, Minnar CM, Stoffel KM, Sturgill IR, Grossenbacher SK, Withers SS, Rebhun RB, Hartigan-O'Connor DJ, Méndez-Lagares G, Tarantal AF, Isseroff RR, Griffith TS, Schalper KA, Merleev A, Saha A, Maverakis E, Kelly K, Aljumaily R, Ibrahimi S, Mukherjee S, Machiorlatti M, Vesely SK, Longo DL, Blazar BR, Canter RJ, Murphy WJ, Monjazeb AM. Paradoxical effects of obesity on T cell function during tumor progression and PD-1 checkpoint blockade. Nat Med. 2019 01; 25(1):141-151. PMID: 30420753.
      Citations: 382     Fields:    Translation:HumansAnimalsCells
    11. Kasht R, Mukherjee S, Ibrahimi S. Degloving the Feet: A Severe Case of Hand-Foot Syndrome After Induction Chemotherapy. J Cutan Med Surg. 2018 Nov/Dec; 22(6):609. PMID: 30322303.
      Citations:    Fields:    Translation:Humans
    12. Mukherjee S, Ibrahimi S, Aljumaily R, Cherry M. Harnessing the PD-1 Pathway in Myelodysplastic Syndrome. Am J Ther. 2018 Nov/Dec; 25(6):e711-e712. PMID: 29394170.
      Citations:    Fields:    Translation:Humans
    13. Mukherjee S, Ibrahimi S, Machiorlatti M, Roman D, Saleem R, Hassan A, Baxley A, Vesely S, Aljumaily R. Personalized Dosing Versus Fixed Dosing of Immune Checkpoint Inhibitors: A Cost Analysis Study. Am J Ther. 2018 Nov/Dec; 25(6):e767-e768. PMID: 29746291.
      Citations: 7     Fields:    Translation:Humans
    14. Mukherjee S, Ibrahimi S, Scordino T, Cherry M. Granulocytic sarcoma and mediastinal germ cell tumor: A common cell of origin? Hematol Oncol Stem Cell Ther. 2019 Dec; 12(4):228-229. PMID: 29913128.
      Citations:    Fields:    Translation:Humans
    15. Khalid B, Mukherjee S, Ibrahimi S, Cannon T, Gilles E, Moreau A, Razaq M. Switching the Smoothened Inhibitor May Have Benefit in Advanced Basal Cell Carcinoma. Am J Ther. 2018 May/Jun; 25(3):e394-e396. PMID: 29557803.
      Citations: 1     Fields:    Translation:Humans
    16. Mukherjee S, Ibrahimi S, Khalid B, Roman D, Zhao D, Aljumaily R. Do proton pump inhibitors modulate the efficacy of anti-PD-1/PD-L1 therapy? A retrospective study. J Oncol Pharm Pract. 2019 04; 25(3):762-764. PMID: 29690815.
      Citations: 17     Fields:    
    17. Ibrahimi S, Vidal G, Mukherjee S, Alhyari L, Scordino T, Cherry M. Sustained response to lenalidomide for early relapsed marginal zone lymphoma. Blood Cells Mol Dis. 2018 07; 71:53-54. PMID: 29496374.
      Citations:    Fields:    Translation:Humans
    18. Mukherjee S, Ayanambakkam A, Ibrahimi S, Schmidt S, Charkrabarty JH, Khawandanah M. Ibritumomab tiuxetan (Zevalin) and elevated serum human anti-murine antibody (HAMA). Hematol Oncol Stem Cell Ther. 2018 Sep; 11(3):187-188. PMID: 29406240.
      Citations: 2     Fields:    Translation:HumansAnimals
    19. Ayanambakkam A, Ibrahimi S, Bilal K, Cherry MA. Extranodal Marginal Zone Lymphoma of the Central Nervous System. Clin Lymphoma Myeloma Leuk. 2018 01; 18(1):34-37.e8. PMID: 29103980.
      Citations: 16     Fields:    Translation:Humans
    20. Mukherjee S, Ibrahimi S, John S, Adnan MM, Scordino T, Khalil MO, Cherry M. Non-seminomatous mediastinal germ cell tumor and acute megakaryoblastic leukemia. Ann Hematol. 2017 Sep; 96(9):1435-1439. PMID: 28578457.
      Citations: 9     Fields:    Translation:Humans
    Ibrahimi's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (89)
    Explore
    _
    Co-Authors (15)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _
    Physical Neighbors
    _